A Bayesian framework for pathway‐guided identification of cancer subgroups by integrating multiple types of genomic data
Statistics in Medicine · 2023
DOI: 10.1002/sim.9911 ↗Kurz gefasst
Fachartikel in der Zeitschrift Statistics in Medicine, 2023. Verfasst von Zequn Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Northwestern University, Chicago, Illinois. Hauptthemen laut MEDLINE: Genomics, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
In recent years, comprehensive cancer genomics platforms, such as The Cancer Genome Atlas (TCGA), provide access to an enormous amount of high throughput genomic datasets for each patient, including gene expression, DNA copy number alterations, DNA methylation, and somatic mutation. While the integration of these multi‐omics datasets has the potential to provide novel insights that can lead to personalized medicine, most existing approaches only focus on gene‐level analysis and lack the ability to facilitate biological findings at the pathway‐level. In this article, we propose Bayes‐InGRiD (Bayesian Integrative Genomics Robust iDentification of cancer subgroups), a novel pathway‐guided Bayesian sparse latent factor model for the simultaneous identification of cancer patient subgroups (clustering) and key molecular features (variable selection) within a unified framework, based on the joint analysis of continuous, binary, and count data. By utilizing pathway (gene set) information, Bayes‐InGRiD does not only enhance the accuracy and robustness of cancer patient subgroup and key molecular feature identification, but also promotes biological understanding and interpretation. Finally, to facilitate an efficient posterior sampling, an alternative Gibbs sampler for logistic and negative binomial models is proposed using Pólya‐Gamma mixtures of normal to represent latent variables for binary and count data, which yields a conditionally Gaussian representation of the posterior. The R package “INGRID” implementing the proposed approach is currently available in our research group GitHub webpage ( https://dongjunchung.github.io/INGRID/ ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Preventive Medicine, Northwestern University, Chicago, Illinois.
- Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio.
- The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
- Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.
- School of Biological Sciences, Queen's University Belfast, Belfast, UK.
- Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina.
ORCID-Profile: Zequn Sun, Dongjun Chung, Brian Neelon, Gary Hardiman
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIDA NIH HHS
- National Cancer Institute
- National Institute of General Medical Sciences
- National Institute on Drug Abuse
Zitieren
APA
Sun, Z., Chung, D., Neelon, B., Millar-Wilson, A., Ethier, S. P., Xiao, F., Zheng, Y., Wallace, K., & Hardiman, G. (2023). A Bayesian framework for pathway‐guided identification of cancer subgroups by integrating multiple types of genomic data. Statistics in Medicine. https://doi.org/10.1002/sim.9911
Vancouver
Sun Z, Chung D, Neelon B, Millar-Wilson A, Ethier SP, Xiao F, et al. A Bayesian framework for pathway‐guided identification of cancer subgroups by integrating multiple types of genomic data. Statistics in Medicine. 2023. doi:10.1002/sim.9911
BibTeX
@article{Sun2023,
author = {Sun, Zequn and Chung, Dongjun and Neelon, Brian and Millar-Wilson, Andrew and Ethier, Stephen P and Xiao, Feifei and Zheng, Yinan and Wallace, Kristin and Hardiman, Gary},
title = {A Bayesian framework for pathway‐guided identification of cancer subgroups by integrating multiple types of genomic data},
journal = {Statistics in Medicine},
year = {2023},
doi = {10.1002/sim.9911}
}
EUVIMED